The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
Open accessAbstract
Background: As a rate‐limiting enzyme of glycolysis, pyruvate kinase muscle isozyme M2 (PKM2) participates in tumor metabolism and growth. The regulatory network of PKM2 in cancer is complex and has not been fully studied in bladder cancer. The 5‐methylcytidine (m5C) modification in PKM2 mRNA might participate in the pathogenesis of bladder cancer and need to be further clarified. This study aimed to investigate the biological function and regulatory mechanism of PKM2 in bladder cancer. Methods: The expression of PKM2 and Aly/REF export factor (ALYREF) was measured by Western blotting, qRT‐PCR, and immunohistochemistry. The bioprocesses of bladder cancer cells were demonstrated by a series of experiments in vitro and in vivo . RNA immunoprecipitation, RNA‐sequencing, and dual‐luciferase reporter assays were conducted to explore the potential regulatory mechanisms of PKM2 in bladder cancer. Results: In bladder cancer, we first demonstrated that ALYREF stabilized PKM2 mRNA and bound to its m5C sites in 3′‐untranslated regions. Overexpression of ALYREF promoted bladder cancer cell proliferation by PKM2‐mediated glycolysis. Furthermore, high expression of PKM2 and ALYREF predicted poor survival in bladder cancer patients. Finally, we found that hypoxia‐inducible factor‐1alpha (HIF‐1α) indirectly up‐regulated the expression of PKM2 by activating ALYREF in addition to activating its transcription directly. Conclusions: The m5C modification in PKM2 mRNA in the HIF‐1α/ALYREF/PKM2 axis may promote the glucose metabolism of bladder cancer, providing a new promising therapeutic target for bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
MODOMICS: a database of RNA modification pathways. 2017 update
Boccaletto, P., Machnicka, M. A., Purta, E., Piątkowski, P., Bagiński, B., Wirecki, T. K., de Crécy-Lagard, V., Ross, R., Limbach, P. A., Kotter, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1030 · Cited by 1,782
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Feng, R., Zong, Y., Cao, S., & Xu, R. (2019) · Cancer Communications · doi:10.1186/s40880-019-0368-6 · Cited by 1,625
Khan, A., Fornes, O., Stigliani, A., Gheorghe, M., Castro-Mondragon, J. A., van der Lee, R., Bessy, A., Chèneby, J., Kulkarni, S. R., Tan, G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1126 · Cited by 1,471
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
PROMO: detection of known transcription regulatory elements using species-tailored searches
Messeguer, X., Escudero, R., Farré, D., Núñez, O., Martı́nez, J., & Albà, M. M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.2.333 · Cited by 1,369
5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader
Yang, X., Yang, Y., Sun, B.-F., Chen, Y.-S., Xu, J.-W., Lai, W.-Y., Li, A., Wang, X., Bhattarai, D. P., Xiao, W., et al. (2017) · Cell Research · doi:10.1038/cr.2017.55 · Cited by 1,062
Self-citationThe dynamic epitranscriptome: N6-methyladenosine and gene expression control
Meyer, K. D., & Jaffrey, S. R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3785 · Cited by 1,060
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,028
Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA
Squires, J. E., Patel, H. R., Nousch, M., Sibbritt, T., Humphreys, D. T., Parker, B. J., Suter, C. M., & Preiss, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks144 · Cited by 1,007
Wang, Q., Chen, C., Ding, Q., Zhao, Y., Wang, Z., Chen, J., Jiang, Z., Zhang, Y., Xu, G., Zhang, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319639 · Cited by 862
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Self-citation5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs
Chen, X., Li, A., Sun, B.-F., Yang, Y., Han, Y.-N., Yuan, X., Chen, R.-X., Wei, W.-S., Liu, Y., Gao, C.-C., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0361-y · Cited by 801
Han, J., Wang, J.-Z., Yang, X., Yu, H., Zhou, R., Lu, H.-C., Yuan, W.-B., Lu, J.-C., Zhou, Z.-J., Lu, Q., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1036-9 · Cited by 709
Self-citationPyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
PKM2, cancer metabolism, and the road ahead
Dayton, T. L., Jacks, T., & Vander Heiden, M. G. (2016) · The EMBO Reports · doi:10.15252/embr.201643300 · Cited by 515
Yang, C., Yuan, W., Yang, X., Li, P., Wang, J., Han, J., Tao, J., Li, P., Yang, H., Lv, Q., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0771-7 · Cited by 515
Self-citationPyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Zahra, K., Dey, T., Ashish, Mishra, S. P., & Pandey, U. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00159 · Cited by 501
m6A-dependent glycolysis enhances colorectal cancer progression
Shen, C., Xuan, B., Yan, T., Ma, Y., Xu, P., Tian, X., Zhang, X., Cao, Y., Ma, D., Zhu, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01190-w · Cited by 437
RNA cytosine methylation analysis by bisulfite sequencing
Schaefer, M., Pollex, T., Hanna, K., & Lyko, F. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn954 · Cited by 419
Cheng, M., Sheng, L., Gao, Q., Xiong, Q., Zhang, H., Wu, M., Liang, Y., Zhu, F., Zhang, Y., Zhang, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0683-z · Cited by 403
Post-transcriptional nucleotide modification and alternative folding of RNA
Helm, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj471 · Cited by 370
Metabolic phenotype of bladder cancer
Massari, F., Ciccarese, C., Santoni, M., Iacovelli, R., Mazzucchelli, R., Piva, F., Scarpelli, M., Berardi, R., Tortora, G., Lopez-Beltran, A., et al. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.03.005 · Cited by 334
PKM2 and cancer: The function of PKM2 beyond glycolysis
DONG, G., MAO, Q., XIA, W., XU, Y., WANG, J., XU, L., & JIANG, F. (2016) · Oncology Letters · doi:10.3892/ol.2016.4168 · Cited by 325
Self-citationBian, Z., Zhang, J., Li, M., Feng, Y., Wang, X., Zhang, J., Yao, S., Jin, G., Du, J., Han, W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2967 · Cited by 305
Genome-wide identification of mRNA 5-methylcytosine in mammals
Huang, T., Chen, W., Liu, J., Gu, N., & Zhang, R. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0218-x · Cited by 289
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
Bringing order to translation: the contributions of transfer RNA anticodon‐domain modifications
Agris, P. F. (2008) · EMBO reports · doi:10.1038/embor.2008.104 · Cited by 232
Yu, H., Yang, X., Tang, J., Si, S., Zhou, Z., Lu, J., Han, J., Yuan, B., Wu, Q., Lu, Q., et al. (2021) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.10.031 · Cited by 205
Self-citationhnRNP C Tetramer Measures RNA Length to Classify RNA Polymerase II Transcripts for Export
McCloskey, A., Taniguchi, I., Shinmyozu, K., & Ohno, M. (2012) · Science · doi:10.1126/science.1218469 · Cited by 191
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
Morita, M., Sato, T., Nomura, M., Sakamoto, Y., Inoue, Y., Tanaka, R., Ito, S., Kurosawa, K., Yamaguchi, K., Sugiura, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.004 · Cited by 171
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Wang, Y., Hao, F., Nan, Y., Qu, L., Na, W., Jia, C., & Chen, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27854 · Cited by 168
Mei, L., Shen, C., Miao, R., Wang, J.-Z., Cao, M.-D., Zhang, Y.-S., Shi, L.-H., Zhao, G.-H., Wang, M.-H., Wu, L.-S., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2487-z · Cited by 164
Self-citationRNA-modifying proteins as anticancer drug targets
Boriack‐Sjodin, P. A., Ribich, S. A., & Copeland, R. A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.71 · Cited by 159
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinomaPreprint
Dayton, T. L., Gocheva, V., Miller, K. M., Israelsen, W. J., Bhutkar, A. J., Clish, C. B., Davidson, S. M., Luengo, A., Bronson, R. T., Jacks, T., et al. (2016) · Genes & Development · doi:10.1101/gad.278549.116 · Cited by 155
Yang, X. F., Cheng, Y., Li, P., Tao, J., Deng, X., Zhang, X., Gu, M., Lü, Q., & Yin, C. (2014) · Tumor Biology · doi:10.1007/s13277-014-2617-2 · Cited by 118
Self-citationRegulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
Xu, Q., Liu, L.-Z., Yin, Y., He, J., Li, Q., Qian, X., You, Y., Lu, Z., Peiper, S. C., Shu, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.6 · Cited by 112
Wang, X., Zhang, F., & Wu, X. (2017) · Scientific Reports · doi:10.1038/srep45983 · Cited by 99
Tao, T., Su, Q., Xu, S., Deng, J., Zhou, S., Yu, Z., Huang, Y., He, C., He, S., Peng, M., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27129 · Cited by 96
Self-citationPKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
Li, T., Wang, S., Shen, X., Zhang, Z., Chen, M., Wang, H., Zhu, Y., Xu, D., Hu, B., Wei, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589997 · Cited by 94
Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers
Domínguez-Sánchez, M. S., Sáez, C., Japón, M. Á., Aguilera, A., & Luna, R. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-77 · Cited by 92
Human C-to-U Coding RNA Editing Is Largely Nonadaptive
Liu, Z., & Zhang, J. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy011 · Cited by 86
Guo, M., Zhao, X., Yuan, X., Jiang, J., & Li, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15999 · Cited by 63
Self-citationMetabolomics in bladder cancer: a systematic review.
Cheng, Y., Yang, X. F., Deng, X., Zhang, X., Li, P., Tao, J., Qin, C., Wei, J., & Lü, Q. (2015) · PubMed · Cited by 61
Self-citationHu, H., Tu, W., Chen, Y., Zhu, M., Jin, H., Huang, T., Zou, Z., & Xia, Q. (2020) · Journal of Cancer · doi:10.7150/jca.38981 · Cited by 48
Hu, C.-Y., Chen, J., Qin, X.-H., You, P., Ma, J., Zhang, J., Zhang, H., & Xu, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01891-0 · Cited by 40
Papadaki, C., Manolakou, S. D., Lagoudaki, E. D., Pontikakis, S., Ierodiakonou, D., Vogiatzoglou, K., Messaritakis, I., Trypaki, M., Giannikaki, L., Sfakianaki, M., et al. (2020) · Cancers · doi:10.3390/cancers12041013 · Cited by 39
Kleszcz, R., Paluszczak, J., Krajka‐Kuźniak, V., & Baer‐Dubowska, W. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/68979 · Cited by 31
PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
Xiao, H. F., Zhang, L., Chen, Y., Zhou, C., Wang, X., Wang, D., & Liu, Z. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/8396023 · Cited by 28
Metadata
- Authors
- Wang, J., Zhu, W., Han, J., Yang, X., Zhou, R., Lu, H., Yu, H., Yuan, W., Li, P., Tao, J., Lu, Q., Wei, J., & Yang, H.
- Venue
- Cancer Communications
- Published
- 2021-05-15
- Volume
- 41
- Issue
- 7
- Pages
- 560-575
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W3163570813
- Cited by
- 313
- References
- 54
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.